Inogen Inc Revenue Growth Rates (INGN), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Inogen Inc   (NASDAQ: INGN)
 

INGN's Revenue Growth by Quarter and Year

Inogen Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

INGN Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -
2nd Quarter June 95.08
1st Quarter March 85.11
FY 180.19

INGNs Annual Revenue
Inogen Inc 's Revenue in the fiscal year 2025 $ 348.67 millions
Inogen Inc 's Revenue in the fiscal year 2024 $ 335.71 millions
Inogen Inc 's Revenue in the fiscal year 2023 $ 315.66 millions
Inogen Inc 's Revenue in the fiscal year 2022 $ 377.24 millions
Inogen Inc 's Revenue in the fiscal year 2021 $ 358.00 millions




INGN Revenue second quarter 2026 Y/Y Growth Comment
Inogen Inc reported Revenue growth of 3.04% year on year in the second quarter 2026, to $ 95.08 millions, this is lower than Inogen Inc 's recent average Revenue increase of 15.3%.

Looking into second quarter 2026 results within Medical Equipment & Supplies industry 122 other companies have achieved higher Revenue growth. While Inogen Inc ' s Revenue increase of 3.04% ranks overall at the positon no. 2459 in the second quarter 2026.


INGN Revenue ( Y/Y Growth %) 2026
 2025 2024 2023
4th Quarter December - 2.05 % 5.51 % -13.84 %
3rd Quarter September - 4.01 % 5.79 % -20.32 %
2nd Quarter June 3.04 % 3.95 % 6.13 % -19.09 %
1st Quarter March 3.44 % 5.45 % 8.13 % -10.24 %
FY   - 3.86 % 6.35 % -

Financial Statements
Inogen Inc 's second quarter 2026 Revenue $ 95.08 millions INGN's Income Statement
Inogen Inc 's second quarter 2025 Revenue $ 92.28 millions Quarterly INGN's Income Statement


INGN Revenue (Quarter on Quarter Growth %)

 2026
 2025 2024 2023
4th Quarter December - -11.55 % -9.85 % -9.61 %
3rd Quarter September - 0.12 % 0.07 % 0.39 %
2nd Quarter June 11.72 % 12.15 % 13.76 % 15.91 %
1st Quarter March 4.15 % 2.75 % 2.81 % -18.08 %
FY (Year on Year)   - 3.86 % 6.35 % -


Back to INGN Growth rate Comparisons >> Back to INGN Growth rate Comparisons >>


Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #123
Healthcare Sector #355
Overall #2459

Revenue Y/Y Growth Statistics
High Average Low
51.65 % 15.3 % -29.06 %
(Dec 31 2018)   (Sep. 30, 2015)
Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #123
Healthcare Sector #355
Overall #2459
Revenue Y/Y Growth Statistics
High Average Low
51.65 % 15.3 % -29.06 %
(Dec 31 2018)   (Sep. 30, 2015)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Inogen Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
30.45 % 4.29 % -18.98 %
(Jun 30 2015)  


INGN's II. Quarter Q/Q Revenue Comment
Inogen Inc achieved in the II. Quarter 2026 above company average sequential Revenue rise of 11.72%, to $ 95.08 millions, from $85.11 millions in the first quarter.

Within Medical Equipment & Supplies industry 30 other companies have achieved higher Revenue quarter on quarter growth. While Inogen Inc 's Revenue growth quarter on quarter, overall rank is 721.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #31
Healthcare Sector #119
Overall #721
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #31
Healthcare Sector #119
Overall #721
Revenue Q/Q Growth Statistics
High Average Low
30.45 % 4.29 % -18.98 %
(Jun 30 2015)  


INGN's II. Quarter Q/Q Revenue Comment
Inogen Inc achieved in the II. Quarter 2026 above company average sequential Revenue rise of 11.72%, to $ 95.08 millions, from $85.11 millions in the first quarter.

Within Medical Equipment & Supplies industry 30 other companies have achieved higher Revenue quarter on quarter growth. While Inogen Inc 's Revenue growth quarter on quarter, overall rank is 721.


Inogen Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)		 12 Months Ending
(Mar 31 2026)		 12 Months Ending
(Dec 31 2025)		 12 Months Ending
(Sep 30 2025)		 12 Months Ending
(Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 354.30 $ 351.50 $ 348.67 $ 347.03 $ 343.47
Y / Y Revenue Growth (TTM) 3.15 % 3.39 % 3.86 % 4.68 % 5.15 %
Year on Year Revenue Growth Overall Ranking # 1924 # 1659 # 988 # 1462 # 2256
Seqeuential Revenue Change (TTM) 0.8 % 0.81 % 0.47 % 1.04 % 1.03 %
Seq. Revenue Growth (TTM) Overall Ranking # 2374 # 2308 # 1434 # 1438 # 1927


Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Jun 30 2026 period, Inogen Inc 's cumulative twelve months Revenue were $ 354 millions, company would post below average annual Revenue growth of 1.03% year on year, if the fiscal year would end at Jun 30 2026.
A slow-down in the Inogen Inc 's Revenue growth from the 85.11% growth in Mar 31 2026.

In the Healthcare sector 295 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1659 to 1924.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 127
Healthcare Sector # 296
Overall # 1924

Revenue TTM Y/Y Growth Statistics
High Average Low
43.57 %
 10.25 %
-24.64 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 127
Sector # 347
S&P 500 # 2374
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Jun 30 2026 period, Inogen Inc 's cumulative twelve months Revenue were $ 354 millions, company would post below average annual Revenue growth of -24.64% year on year, if the fiscal year would end at Jun 30 2026.
A slow-down in the Inogen Inc 's Revenue growth from the 85.11% growth in Mar 31 2026.

In the Healthcare sector 295 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1659 to 1924.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 127
Healthcare Sector # 296
Overall # 1924

Revenue TTM Y/Y Growth Statistics
High Average Low
43.57 %
10.25 %
-24.64 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 127
Sector # 347
S&P 500 # 2374




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
INGN's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue rise for the quarter ending Jun 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2026
Bruker Corporation5.22%$ 5.220 millions
Davita Inc 5.17%$ 5.165 millions
Park Dental Partners Inc 5.10%$ 5.102 millions
Lumexa Imaging Holdings Inc 5.08%$ 5.076 millions
Merck and Co Inc 5.07%$ 5.068 millions
Cv Sciences Inc 4.96%$ 4.958 millions
Viatris Inc 4.88%$ 4.877 millions
Fulgent Genetics Inc 4.86%$ 4.855 millions
Zimmer Biomet Holdings Inc 4.80%$ 4.799 millions
Mettler toledo International Inc 4.48%$ 4.485 millions
Phibro Animal Health Corporation4.40%$ 4.405 millions
Align Technology inc 4.35%$ 4.355 millions
Opko Health Inc 4.32%$ 4.319 millions
Dariohealth Corp 4.29%$ 4.291 millions
Orthofix Medical Inc 4.15%$ 4.147 millions
Pediatrix Medical Group Inc 4.04%$ 4.040 millions
Nrc Health3.98%$ 3.978 millions
Bioventus Inc 3.76%$ 3.757 millions
Heron Therapeutics Inc 3.64%$ 3.640 millions
Prime Medicine Inc 3.50%$ 3.498 millions
Inogen Inc 3.04%$ 3.042 millions
Pacific Health Care Organization Inc2.79%$ 2.786 millions
Quidelortho Corp2.77%$ 2.769 millions
C4 Therapeutics Inc 2.75%$ 2.754 millions
Surgery Partners Inc 2.75%$ 2.748 millions
Lantheus Holdings Inc 2.69%$ 2.690 millions
Healthcare Services Group Inc 2.69%$ 2.686 millions
Adma Biologics Inc 2.61%$ 2.613 millions
Pfizer Inc2.60%$ 2.600 millions
Infusystem Holdings Inc2.59%$ 2.586 millions


About Inogen Inc Revenue Growth Rates (INGN), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Inogen Inc (CIK 1294133).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001294133-26-000034
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Inogen Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.